News

Avenue Therapeutics Showcases Insights at Healthcare Summit

Avenue Therapeutics Showcases Insights at Healthcare Summit

Avenue Therapeutics Set to Shine at Upcoming Healthcare Summit

MIAMI, Oct. 09, 2024 — Avenue Therapeutics, Inc. (Nasdaq: ATXI), a dedicated specialty pharmaceutical company, is gearing up for an impactful presence at the upcoming Maxim Group’s 2024 Healthcare Virtual Summit. On this important occasion, Alexandra MacLean, M.D., the Chief Executive Officer of Avenue Therapeutics, will engage in a compelling fireside chat designed to foster meaningful discussions around the company's role in advancing therapies for neurologic diseases.

Insightful Discussions on Neurologic Therapies

This engaging session will take place on Tuesday, October 15, and is set to provide valuable insights for registered attendees. Avenue Therapeutics has positioned itself as a pioneer in the development and commercialization of innovative treatments specifically aimed at neurologic conditions.

What to Expect from the Fireside Chat

During the discussion, Dr. MacLean is expected to elaborate on the company's strategic initiatives, including updates on their current projects and future aspirations. Avenue Therapeutics is committed to addressing unmet medical needs in neurologic conditions, ensuring they remain at the forefront of the industry.

Avenue Therapeutics' Innovative Portfolio

Currently, Avenue Therapeutics is advancing three notable assets that showcase its commitment to enhancing patient outcomes. Among these, AJ201 stands out as a first-in-class treatment intended for spinal and bulbar muscular atrophy. Another promising asset is BAER-101, an oral medication designed as a selective GABAA ?2, ?3 receptor positive allosteric modulator aimed at benefiting patients with various CNS disorders.

Focusing on Postoperative Pain Management

In addition to their impressive research pipeline, Avenue is also developing IV tramadol, which targets the management of acute postoperative pain in adults. This therapy is designed for use in medically supervised healthcare settings, ensuring that patients receive the highest level of care during recovery periods.

Company Background and Vision

Founded by Fortress Biotech, Inc. (Nasdaq: FBIO), Avenue Therapeutics is headquartered in Miami, Florida. The company’s mission is to bridge gaps in current treatment methodologies by offering state-of-the-art solutions for neurologic disorders. With a skilled team and strong vision, Avenue Therapeutics is poised to make a significant impact in the pharmaceutical landscape.

Contact Avenue Therapeutics for More Information

For those intrigued by Avenue Therapeutics’ mission or who wish to learn more about their innovative therapies, additional information is readily available on their official website. Moreover, questions can be directed to Jaclyn Jaffe at Avenue Therapeutics. She can be reached at (781) 652-4500 or via email.

Frequently Asked Questions

What is Avenue Therapeutics focused on?

Avenue Therapeutics focuses on developing and commercializing therapies for neurologic diseases.

Who will be speaking at the Maxim Group’s 2024 Healthcare Summit?

Alexandra MacLean, M.D., the CEO of Avenue Therapeutics, will participate in a fireside chat.

What are the key assets being developed by Avenue Therapeutics?

Key assets include AJ201, BAER-101, and IV tramadol aimed at treating various neurologic conditions.

How can investors attend the fireside chat?

Investors can sign up or log in as registered attendees for the healthcare summit.

Where is Avenue Therapeutics headquartered?

Avenue Therapeutics is headquartered in Miami, Florida.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 3

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading

Top 5 Most Recently Viewed Articles

Siili Solutions plc Announces Strategic Share Buyback Decision

Updated Category News Views 103

Siili Solutions Plc Announces Share Repurchase Siili Solutions Plc has made an impactful announcement regarding their share repurchase initiative. This decision is critical as it reflects the company's strategic focus on optimizing shareholder value and enhancing the overall market presence. Details of the Share Repurchase On June 30, 2025, Siili Solutions Plc engaged in...

Continue Reading
Vizsla Silver Expands Exploration and Targets New Opportunities

Updated Category News Views 128

Advancing Exploration Initiatives Vizsla Silver Corp. (NYSE: VZLA, TSX: VZLA) is taking significant strides to enhance its exploration efforts at the Panuco District, focusing on both the existing resources and new targets. The latest updates from the site showcase the company's commitment to maximizing the potential of the area known for its high-grade silver and gold...

Continue Reading
RE/MAX Alliance Group Enhances Market Presence with Merger

Updated Category News Views 1305

RE/MAX Alliance Group Merges to Expand Its Reach RE/MAX Alliance Group has recently announced an exciting merger that significantly boosts its presence in the real estate market. This merger combines the strength of RE/MAX Alliance Group with RE/MAX Anchor and RE/MAX Affinity Plus, adding more than 120 agents and staff to its ranks. This strategic move represents a...

Continue Reading
Nordic Semiconductor Enhances Chip-to-Cloud Lifecycle Management

Updated Category News Views 205

Nordic Semiconductor Revolutionizes Lifecycle Management Becomes the first semiconductor company to combine best-in-class hardware, software, and cloud services – transforming how connected products are built, deployed, and upgraded to address rapidly evolving requirements and increasing software complexity. Nordic Semiconductor, recognized as a key player in low-power...

Continue Reading
Else Nutrition Prepares for 2025 Business Update and More

Updated Category News Views 222

Else Nutrition's Upcoming Business Update Conference Call Else Nutrition Holdings Inc. (NASDAQ: BABYF) has announced its plans to host an important business update conference call. Scheduled for 10:00 a.m. Eastern Time on September 16, 2025, this call will provide insights into the company's financial results for the second quarter of 2025 and an overview of corporate...

Continue Reading